2-(3-Cyanophenyl))-7-ethoxycarbonyl)-5,6,7,8-tetrahydropyridylthieno[2,3-d]pyrimidin-4(3H)-one

ID: ALA4761219

PubChem CID: 162659602

Max Phase: Preclinical

Molecular Formula: C19H16N4O3S

Molecular Weight: 380.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOC(=O)N1CCc2c(sc3nc(-c4cccc(C#N)c4)[nH]c(=O)c23)C1

Standard InChI:  InChI=1S/C19H16N4O3S/c1-2-26-19(25)23-7-6-13-14(10-23)27-18-15(13)17(24)21-16(22-18)12-5-3-4-11(8-12)9-20/h3-5,8H,2,6-7,10H2,1H3,(H,21,22,24)

Standard InChI Key:  BPZJRUWEVKXTOF-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   30.9583   -3.3967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9583   -4.2180    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.6677   -4.6266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6677   -2.9840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3772   -3.3967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3816   -4.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1610   -4.4658    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   33.1537   -3.1411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6308   -3.7994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4354   -3.7138    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7694   -2.9710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2882   -2.3127    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.4773   -2.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5839   -2.8865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0640   -3.5491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8801   -3.4638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2171   -2.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7278   -2.0496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9134   -2.1382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9949   -1.7335    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.0541   -1.3024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3822   -0.5540    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2508   -4.6270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5429   -4.2188    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.8354   -4.6277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1275   -4.2195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2513   -5.4442    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 11 14  1  0
 13 20  2  0
 21 22  3  0
 18 21  1  0
  2 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  2  0
M  END

Alternative Forms

  1. Parent:

    ALA4761219

    ---

Associated Targets(Human)

KB-V1 (202 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
518A2 (464 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EA.hy 926 (491 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.43Molecular Weight (Monoisotopic): 380.0943AlogP: 3.04#Rotatable Bonds: 2
Polar Surface Area: 99.08Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.84CX Basic pKa: 0.52CX LogP: 2.75CX LogD: 2.63
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -2.20

References

1. Gold M,Köhler L,Lanzloth C,Andronache I,Anant S,Dandawate P,Biersack B,Schobert R.  (2020)  Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones.,  189  [PMID:31958738] [10.1016/j.ejmech.2020.112060]

Source